Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• Advances in Anticoagulation • Duhon


Advances in Anticoagulation

Summary:
In this activity, Dr Duhon reviews recent developments in anticoagulation therapy, lists key prescribing points and safety concerns, discusses switching between anticoagulation agents, and identifies options for reversing anticoagulants. 
Target Audience:
This course is designed for pharmacists. 
Program Design:
This course is presented in a lecture format, available via MP4 files, and is accompanied by PDFs of the presenter's PowerPoint slides.  A post-test and program evaluation will be completed after reviewing the content of each presentation.  The post-test and evaluation must be completed BEFORE Aug 1, 2017.
Note:  The video and PDF documents were developed to work on most computers, tablet, and smartphones. 
Content previously recorded at the 62nd Pharmacy Practice Seminar, filmed on September 14, 2014.

Fee

$15.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

 
ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.10 CEUs (1.00 contact hours) of continuing education credit.  In order to receive 1.00 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. 

 

 

 

Objectives

  • Review recent developments in anticoagulation therapy
  • List the key prescribing points, safety concerns, and monitoring parameters for each anticoagulant
  • Discuss switching between anticoagulation agents
  • Identity options for reversing anticoagulants

Activity Number

0067-0000-14-012-H01-P

Release Date: Sep 13, 2014
Credit Expiration Date: Sep 1, 2017

CE Hours

1.00